Stocks Close Out A Big First Quarter… And The True Cost Of Diabetes Drugs 3/28/24
Q1 is in the books, and stocks are heading into Q2 with some major accomplishments. Can the market rally keep raging? And where you should be positioned going into the second quarter. Plus… what it really costs to craft these diabetes drugs. A new study pointing to a $5 price tag for a month’s worth of one blockbuster…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from CNBC's "Fast Money"
See all episodes →Yields Spike As Consumer Confidence Drops… And Altman Weighs In On AI Pacing 9/29/26
Rates Keep Rising… And The Quiet Playbook For A Noisy Market 9/28/26
Market Resilience Despite Surge In Yields… And Options Action Ahead Of Micron Results 9/25/26
Similar episodes from other shows
More like CNBC's "Fast Money" →
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.